Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer
AUAUniversity17 Okt 2019

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

Co-Host: Maxwell Meng, MD At the conclusion of these activities, participants will be able to: 1. Identify treatments for non-metastatic and metastatic CRPC and describe the proper order for their administration. 2. Manage nm and mCRPC with systemic agents by learning the proper candidates for treatment and be able to counsel patients on the pros and cons of therapy. 3. Review the newer generation antiandrogen agents and their use in nmCRPC and in mCRPC. CME Available: auau.auanet.org/node/26067 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma

Avsnitt(434)

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
harrisons-dramatiska-historia
nu-blir-det-historia
allt-du-velat-veta
johannes-hansen-podcast
not-fanny-anymore
rss-viktmedicinpodden
roda-vita-rosen
rss-foraldramotet-bring-lagercrantz
sektledare
i-vantan-pa-katastrofen
sa-in-i-sjalen
rss-max-tant-med-max-villman
rss-sjalsligt-avkladd
alska-oss
rss-basta-livet
rss-om-vi-ska-vara-arliga
rikatillsammans-om-privatekonomi-rikedom-i-livet